Impact of margin status on survival following pancreatoduodenectomy for cancer: the Leeds Pathology Protocol (LEEPP).
about
A systematic review of the role of periadventitial dissection of the superior mesenteric artery in affecting margin status after pancreatoduodenectomy for pancreatic adenocarcinomaAdvances in chemotherapy for pancreatic cancerSequential neoadjuvant chemoradiotherapy (CRT) followed by curative surgery vs. primary surgery alone for resectable, non-metastasized pancreatic adenocarcinoma: NEOPA- a randomized multicenter phase III study (NCT01900327, DRKS00003893, ISRCTN82191Current and future intraoperative imaging strategies to increase radical resection rates in pancreatic cancer surgery.Neoadjuvant chemoradiation therapy with gemcitabine/cisplatin and surgery versus immediate surgery in resectable pancreatic cancer: results of the first prospective randomized phase II trial.Intestinal-type of differentiation predicts favourable overall survival: confirmatory clinicopathological analysis of 198 periampullary adenocarcinomas of pancreatic, biliary, ampullary and duodenal originRadiologic and intraoperative detection of need for mesenteric vein resection in patients with adenocarcinoma of the head of the pancreasComparison of Pathological Radicality between Open and Laparoscopic Pancreaticoduodenectomy in a Tertiary Centre.Locally advanced pancreatic head cancer: margin-positive resection or bypass?Palliation With Endoscopic Metal Stents May Be Preferable to Surgical Intervention for Patients With Obstructive Pancreatic Head AdenocarcinomaImpact of Resection Margin Distance on Survival of Pancreatic Cancer: A Systematic Review and Meta-Analysis.Results of pancreatic surgery in the elderly: is age a barrier?A model to predict survival following pancreaticoduodenectomy for malignancy based on tumour site, stage and lymph node ratio.Redefining resection margin status in pancreatic cancerResection margins in pancreatic cancer: are we entering a new era?Friday, February 21, 2014, 5:00pm–6:30pm Oral Poster I (Liver I, II; Pancreas I, II; Biliary I; Transplant I; Other)Standardization of surgical and pathologic variables is needed in multicenter trials of adjuvant therapy for pancreatic cancer: results from the ACOSOG Z5031 trial.An in vivo evaluation of cerebral cortical amyloid with [18F]flutemetamol using positron emission tomography compared with parietal biopsy samples in living normal pressure hydrocephalus patients.Redefining the R1 resection for pancreatic ductal adenocarcinoma: tumour lymph nodal burden and lymph node ratio are the only prognostic factors associated with survival.Use of a standardized diagnostic approach improves the prognostic information of histopathologic factors in pancreatic and periampullary adenocarcinoma.Radiotherapy in the adjuvant management of pancreatic adenocarcinoma: is it helpful?Resection margin involvement and tumour origin in pancreatic head cancer.Is there a 'margin' for error in pancreatic cancer surgery?Pathology for the HPB Surgeon.Resection margins in pancreatic cancer.Surgical techniques for improving outcomes in pancreatic ductal adenocarcinoma.Prognostic factors related with survival in patients with pancreatic adenocarcinomaPathology of pancreatic ductal adenocarcinoma: facts, challenges and future developments.Robotic surgery of the pancreas: The current state of the art.Artery first approach to pancreatoduodenectomy: current status.Meta-analysis of radical resection rates and margin assessment in pancreatic cancer.Outcome and evaluation of prognostic factors after pancreaticoduodenectomy for distal cholangiocarcinoma.The importance of surgical margins in pancreatic cancer.Reporting the margin in pancreaticoduodenectomies: R0 versus R1.Redefining the R1 resection in patients with pancreatic ductal adenocarcinoma.Detailed analysis of epithelial-mesenchymal transition and tumor budding identifies predictors of long-term survival in pancreatic ductal adenocarcinoma.The role of irreversible electroporation (IRE) for locally advanced pancreatic cancer: a systematic review of safety and efficacy.Para-aortic node involvement is not an independent predictor of survival after resection for pancreatic cancer.Impact of lymph node ratio on survival in patients with pancreatic and periampullary cancer.Mesenteric-Portal Vein Resection during Pancreatectomy for Pancreatic Cancer.
P2860
Q26748880-1EDB8C1A-769C-461F-AB7A-8FC6CB20CC1CQ28085711-C931A1F6-3DB9-493B-AE12-1A53A10D8B9CQ33755147-D4696332-7274-403B-95C1-4FA64EC8EAC9Q34009539-8D7FE6C5-297B-4233-9195-7AA3E262E6A6Q34891512-E32E9FC8-C17D-444E-9DBE-1E8B90532808Q34992861-24336E75-FA0F-444E-BD2D-6BA153574DFFQ35244224-8D3D04C2-0819-4393-859D-C516B7940567Q35547773-EDE33814-D74A-4CD9-A4EE-3C204D1BA20DQ36065278-F688F4F1-31D3-4A69-B619-C342DBA47F36Q36104305-B1F883FA-15F7-419D-910E-4967CC6E5B4DQ36113317-7478461D-2DAD-4B6E-9834-CA4A31726670Q36498469-A11C797A-A75C-4BF8-9DE6-35BA24495B88Q36747404-505D844A-8CCE-4851-B336-D0AB4BE8230EQ37305587-4E9C1A44-8186-4E24-9CC6-328279F79D08Q37480810-FE8480C8-ACAD-440D-929E-BE255B36A7A6Q37480826-1B898113-7532-4643-951B-A851D516D56EQ37579741-D904D7BB-DC20-44C9-B450-9CA61070B0E0Q37605374-F3B863CC-0207-42CD-B7FF-17E146CC8DCBQ37628439-B1DC3767-98F3-44D7-BF08-79074D474514Q37722822-8DC198FC-72BF-4D48-9071-7405C84B5FC1Q37989158-C1C87A4B-8881-42CF-B798-FA091AAEBD9DQ38003878-072F1B63-F506-4545-9939-AB3EA48F0CACQ38068490-5551DB6E-F50D-4C32-BAD0-A856D3E558C0Q38078346-DAE70B4C-6EBB-44E4-B301-F2358386A6CDQ38160324-059E557A-5CCA-4126-8573-A090F1111B5AQ38184666-859B95E8-C2D3-4C04-8950-FB8043CF64D8Q38242807-BA626AFA-8A92-4D01-AE9A-85004A3D768BQ38260683-88754FB2-1AF1-41E6-85F5-109AAD63ED15Q38556594-6DD0478F-0140-43D5-960A-0DF5E13F69E7Q38561432-AA394415-8471-40DC-83D6-99820EBC6143Q38582990-A0177B72-F06D-4B05-BB16-3BBB164F3322Q38606303-E45898D7-1F6D-4E0A-B2AE-B5C1584D055CQ38646898-DFF83612-311E-454F-A3AD-359828EACB20Q38833318-661FB373-37AB-43F9-BD14-C3648D2A17A1Q38927638-91148361-48A8-42E5-A2E5-527D1485E2D2Q39023133-F9BC86CD-5603-493E-AC6D-50529A402757Q39421330-F0CC22EE-B12C-4D1F-BCE6-3AD8AC2B2774Q41024357-AABA5777-25E7-47B0-8226-1A1CC155DF04Q41663095-679ACA11-BDC0-4BED-AA16-9F199E0B3616Q41984818-7A26ED2F-C6E6-4DF3-B768-680DDA97C97F
P2860
Impact of margin status on survival following pancreatoduodenectomy for cancer: the Leeds Pathology Protocol (LEEPP).
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Impact of margin status on sur ...... ds Pathology Protocol (LEEPP).
@en
Impact of margin status on sur ...... : the Leeds Pathology Protocol
@nl
type
label
Impact of margin status on sur ...... ds Pathology Protocol (LEEPP).
@en
Impact of margin status on sur ...... : the Leeds Pathology Protocol
@nl
prefLabel
Impact of margin status on sur ...... ds Pathology Protocol (LEEPP).
@en
Impact of margin status on sur ...... : the Leeds Pathology Protocol
@nl
P2093
P2860
P1476
Impact of margin status on sur ...... eds Pathology Protocol (LEEPP)
@en
P2093
Alan Anthoney
Andrew M Smith
Dhanwant Gomez
Krishna V Menon
P2860
P356
10.1111/J.1477-2574.2008.00013.X
P50
P577
2009-02-01T00:00:00Z